Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.5K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.5K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

119
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
119

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Building Health from Childhood: One Health Strategies for Obesity Prevention and Nutritional Education in Italy.

Journal of prevention (2022)·2026
Same author

Outcomes of standardized drain-free abdominoplasty after massive weight loss: A retrospective analysis of 2533 post-bariatric patients.

JPRAS open·2026
Same author

The Shifting Paradigm of Monoclonal Antibodies in COVID-19 Management: From Early Triumphs to Viral Resistance and Future Perspectives.

Antibodies (Basel, Switzerland)·2026
Same author

An Italian regional analysis on chronic obstructive pulmonary disease (COPD): correct diagnosis and lifestyle play a fundamental role in supporting drug therapy and containing healthcare costs.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

Prognostic Impact of miR-34a in Head and Neck Squamous Cell Carcinoma: A Systematic Review with Meta-Analysis and Trial Sequential Analysis.

International journal of molecular sciences·2026
Same author

Development and Real-World Application of a Consumption-Based Model for Projecting the Budget Impact of High-Cost Reserve Antibiotics in a University Hospital.

Value in health regional issues·2026

Related Experiment Video

Updated: Mar 16, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K

Hepatitis D Infection: a puzzle still unsolved?

Antonio Vitiello1, Mariarosaria Boccellino2, Giacomo Polito3

  • 1Department of health prevention, Research and emergencies, Italian Ministry of Health, Rome, 00144, Italy.

Virology
|March 14, 2026
PubMed
Summary

Hepatitis D Virus (HDV) infection is a severe liver disease affecting millions globally. Recent therapeutic research offers new hope for effective treatments against this challenging viral hepatitis.

Keywords:
DrugsHBVHDVInnovationVirus

More Related Videos

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

18.9K
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.5K

Related Experiment Videos

Last Updated: Mar 16, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

10.4K
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

18.9K
Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
11:36

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms

Published on: May 29, 2020

3.5K

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Hepatitis D Virus (HDV), or "delta" hepatitis, is the most severe form of viral hepatitis.
  • HDV affects approximately 5% of individuals with chronic Hepatitis B Virus (HBV) infection, impacting 10-20 million people worldwide.
  • Despite its discovery over 40 years ago, understanding of HDV and its associated disease remains limited.

Purpose of the Study:

  • To highlight recent advances in therapeutic research for Hepatitis D.
  • To underscore the potential for new treatments for HDV infection.
  • To provide an overview of the current state of Hepatitis D understanding and future treatment prospects.

Main Methods:

  • Review of recent therapeutic research and pharmacological approaches for Hepatitis D.
  • Analysis of the global impact and prevalence of HDV infection.
  • Synthesis of current knowledge regarding HDV and its clinical implications.

Main Results:

  • Recent therapeutic research indicates significant progress in developing targeted therapies for HDV.
  • Combination pharmacological approaches are being explored to enhance treatment efficacy.
  • A breakthrough in treating this severe viral infection is anticipated with ongoing research.

Conclusions:

  • Despite knowledge gaps, recent advances offer hope for patients with Hepatitis D.
  • The development of novel targeted therapies and combined treatments signifies a promising future for HDV management.
  • Continued research is crucial for fully understanding and effectively treating Hepatitis D Virus infection.